Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Colorectal Neoplasms

Free Subscription Articles published in Gut Retrieve available abstracts of 56 articles: HTML format Text format

Single Articles

February 2019
1. CHEUNG KS, Chen L, Chan EW, Seto WK, et al
   Statins reduce the progression of non-advanced adenomas to colorectal cancer: a postcolonoscopy study in 187 897 patients.
   Gut. 2019 Feb 26. pii: gutjnl-2018-317714. doi: 10.1136/gutjnl-2018-317714.
   PubMed     Text format     Abstract available
   
   
   
2. HE Z, Gharaibeh RZ, Newsome RC, Pope JL, et al
   Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin.
   Gut. 2019;68:289-300.
   PubMed     Text format     Abstract available
   
   
   
3. NGU WS, Bevan R, Tsiamoulos ZP, Bassett P, et al
   Improved adenoma detection with Endocuff Vision: the ADENOMA randomised controlled trial.
   Gut. 2019;68:280-288.
   PubMed     Text format     Abstract available
   
   
   January 2019
4. LOPEZ A, Bouvier AM, Jooste V, Cottet V, et al
   Outcomes following polypectomy for malignant colorectal polyps are similar to those following surgery in the general population.
   Gut. 2019;68:111-117.
   PubMed     Text format     Abstract available
   
   
   December 2018
5. STJARNGRIM J, Ekbom A, Hammar U, Hultcrantz R, et al
   Rates and characteristics of postcolonoscopy colorectal cancer in the Swedish IBD population: what are the differences from a non-IBD population?
   Gut. 2018 Dec 15. pii: gutjnl-2018-316651. doi: 10.1136/gutjnl-2018-316651.
   PubMed     Text format     Abstract available
   
   
   
6. SENORE C, Basu P, Anttila A, Ponti A, et al
   Performance of colorectal cancer screening in the European Union Member States: data from the second European screening report.
   Gut. 2018 Dec 10. pii: gutjnl-2018-317293. doi: 10.1136/gutjnl-2018-317293.
   PubMed     Text format     Abstract available
   
   
   
7. LADABAUM U
   Occult blood in faeces: a window into health beyond the colorectum?
   Gut. 2018;67:2079-2080.
   PubMed     Text format    
   
   
   November 2018
8. COKER OO, Nakatsu G, Dai RZ, Wu WKK, et al
   Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer.
   Gut. 2018 Nov 24. pii: gutjnl-2018-317178. doi: 10.1136/gutjnl-2018-317178.
   PubMed     Text format     Abstract available
   
   
   
9. BAHIN FF, Heitman SJ, Rasouli KN, Mahajan H, et al
   Wide-field endoscopic mucosal resection versus endoscopic submucosal dissection for laterally spreading colorectal lesions: a cost-effectiveness analysis.
   Gut. 2018;67:1965-1973.
   PubMed     Text format     Abstract available
   
   
   
10. BUGAJSKI M, Wieszczy P, Hoff G, Rupinski M, et al
    Modifiable factors associated with patient-reported pain during and after screening colonoscopy.
    Gut. 2018;67:1958-1964.
    PubMed     Text format     Abstract available
    
    
    October 2018
11. CHEN H, Li N, Ren J, Feng X, et al
    Participation and yield of a population-based colorectal cancer screening programme in China.
    Gut. 2018 Oct 30. pii: gutjnl-2018-317124. doi: 10.1136/gutjnl-2018-317124.
    PubMed     Text format     Abstract available
    
    
    
12. DEKKER E, IJspeert JEG
    Serrated pathway: a paradigm shift in CRC prevention.
    Gut. 2018;67:1751-1752.
    PubMed     Text format    
    
    
    
13. GERNER RR, Klepsch V, Macheiner S, Arnhard K, et al
    NAD metabolism fuels human and mouse intestinal inflammation.
    Gut. 2018;67:1813-1823.
    PubMed     Text format     Abstract available
    
    
    September 2018
14. GUDRA D, Shoaie S, Fridmanis D, Klovins J, et al
    A widely used sampling device in colorectal cancer screening programmes allows for large-scale microbiome studies.
    Gut. 2018 Sep 21. pii: gutjnl-2018-316225. doi: 10.1136/gutjnl-2018-316225.
    PubMed     Text format    
    
    
    
15. TOES-ZOUTENDIJK E, Kooyker AI, Elferink MA, Spaander MCW, et al
    Stage distribution of screen-detected colorectal cancers in the Netherlands.
    Gut. 2018;67:1745-1746.
    PubMed     Text format    
    
    
    
16. TOYOSHIMA O, Hata K, Yoshida S, Arita M, et al
    New-generation chromoendoscopy may increase confidence in the DISCARD2 study.
    Gut. 2018;67:1742-1743.
    PubMed     Text format    
    
    
    
17. MURPHY G, Cross AJ, Dawsey SM, Stanczyk FZ, et al
    Serum ghrelin is associated with risk of colorectal adenocarcinomas in the ATBC study.
    Gut. 2018;67:1646-1651.
    PubMed     Text format     Abstract available
    
    
    August 2018
18. POHL H, Kaminski MF
    Mindful choice of endoscopic resection for large colorectal lesions.
    Gut. 2018;67:1374-1375.
    PubMed     Text format    
    
    
    
19. FUCCIO L, Repici A, Hassan C, Ponchon T, et al
    Why attempt en bloc resection of non-pedunculated colorectal adenomas? A systematic review of the prevalence of superficial submucosal invasive cancer after endoscopic submucosal dissection.
    Gut. 2018;67:1464-1474.
    PubMed     Text format     Abstract available
    
    
    July 2018
20. LIBBY G, Fraser CG, Carey FA, Brewster DH, et al
    Occult blood in faeces is associated with all-cause and non-colorectal cancer mortality.
    Gut. 2018 Jul 16. pii: gutjnl-2018-316483. doi: 10.1136/gutjnl-2018-316483.
    PubMed     Text format     Abstract available
    
    
    
21. BAKER AM, Cross W, Curtius K, Al Bakir I, et al
    Evolutionary history of human colitis-associated colorectal cancer.
    Gut. 2018 Jul 10. pii: gutjnl-2018-316191. doi: 10.1136/gutjnl-2018-316191.
    PubMed     Text format     Abstract available
    
    
    
22. CHANG WL, Jackson C, Riel S, Cooper HS, et al
    Differential preventive activity of sulindac and atorvastatin in Apc(+/Min-FCCC)mice with or without colorectal adenomas.
    Gut. 2018;67:1290-1298.
    PubMed     Text format     Abstract available
    
    
    June 2018
23. KOMIYA Y, Shimomura Y, Higurashi T, Sugi Y, et al
    Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity.
    Gut. 2018 Jun 22. pii: gutjnl-2018-316661. doi: 10.1136/gutjnl-2018-316661.
    PubMed     Text format    
    
    
    
24. WIETEN E, Schreuders EH, Grobbee EJ, Nieboer D, et al
    Incidence of faecal occult blood test interval cancers in population-based colorectal cancer screening: a systematic review and meta-analysis.
    Gut. 2018 Jun 22. pii: gutjnl-2017-315340. doi: 10.1136/gutjnl-2017-315340.
    PubMed     Text format     Abstract available
    
    
    
25. NIEUWENBURG SAV, Vuik FER, Kruip MJHA, Kuipers EJ, et al
    Effect of anticoagulants and NSAIDs on accuracy of faecal immunochemical tests (FITs) in colorectal cancer screening: a systematic review and meta-analysis.
    Gut. 2018 Jun 5. pii: gutjnl-2018-316344. doi: 10.1136/gutjnl-2018-316344.
    PubMed     Text format     Abstract available
    
    
    May 2018
26. GLUCK N, Half EE, Bieber V, Schwartz D, et al
    Novel prep-less X-ray imaging capsule for colon cancer screening: a feasibility study.
    Gut. 2018 May 21. pii: gutjnl-2018-316127. doi: 10.1136/gutjnl-2018-316127.
    PubMed     Text format    
    
    
    
27. BARENDSE RM, Musters GD, de Graaf EJR, van den Broek FJC, et al
    Randomised controlled trial of transanal endoscopic microsurgery versus endoscopic mucosal resection for large rectal adenomas (TREND Study).
    Gut. 2018;67:837-846.
    PubMed     Text format     Abstract available
    
    
    April 2018
28. SMITH T, Muller DC, Moons KGM, Cross AJ, et al
    Comparison of prognostic models to predict the occurrence of colorectal cancer in asymptomatic individuals: a systematic literature review and external validation in the EPIC and UK Biobank prospective cohort studies.
    Gut. 2018 Apr 3. pii: gutjnl-2017-315730. doi: 10.1136/gutjnl-2017-315730.
    PubMed     Text format     Abstract available
    
    
    
29. CAO Y, Wu K, Mehta R, Drew DA, et al
    Long-term use of antibiotics and risk of colorectal adenoma.
    Gut. 2018;67:672-678.
    PubMed     Text format     Abstract available
    
    
    
30. MOUSSATA D, Allez M, Cazals-Hatem D, Treton X, et al
    Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?
    Gut. 2018;67:616-624.
    PubMed     Text format     Abstract available
    
    
    
31. BATTERSBY NJ, Bouliotis G, Emmertsen KJ, Juul T, et al
    Development and external validation of a nomogram and online tool to predict bowel dysfunction following restorative rectal cancer resection: the POLARS score.
    Gut. 2018;67:688-696.
    PubMed     Text format     Abstract available
    
    
    March 2018
32. JOO JE, Jayasekara H, Wong EM, Clendenning M, et al
    Assessing the ProMCol classifier as a prognostic marker for non-metastatic colorectal cancer within the Melbourne Collaborative Cohort Study.
    Gut. 2018 Mar 24. pii: gutjnl-2018-316122. doi: 10.1136/gutjnl-2018-316122.
    PubMed     Text format    
    
    
    
33. RIGTER LS, Snaebjornsson P, Rosenberg EH, Atmodimedjo PN, et al
    Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment.
    Gut. 2018;67:447-455.
    PubMed     Text format     Abstract available
    
    
    
34. DAVENPORT JR, Su T, Zhao Z, Coleman HG, et al
    Modifiable lifestyle factors associated with risk of sessile serrated polyps, conventional adenomas and hyperplastic polyps.
    Gut. 2018;67:456-465.
    PubMed     Text format     Abstract available
    
    
    February 2018
35. SUNDKVIST A, Myte R, Palmqvist R, Harlid S, et al
    Plasma ghrelin is probably not a useful biomarker for risk prediction or early detection of colorectal cancer.
    Gut. 2018 Feb 28. pii: gutjnl-2018-316110. doi: 10.1136/gutjnl-2018-316110.
    PubMed     Text format    
    
    
    
36. CREMONESI E, Governa V, Garzon JFG, Mele V, et al
    Gut microbiota modulate T cell trafficking into human colorectal cancer.
    Gut. 2018 Feb 6. pii: gutjnl-2016-313498. doi: 10.1136/gutjnl-2016-313498.
    PubMed     Text format     Abstract available
    
    
    
37. OVERWATER A, Kessels K, Elias SG, Backes Y, et al
    Endoscopic resection of high-risk T1 colorectal carcinoma prior to surgical resection has no adverse effect on long-term outcomes.
    Gut. 2018;67:284-290.
    PubMed     Text format     Abstract available
    
    
    
38. RICHARDS CH, Ventham NT, Mansouri D, Wilson M, et al
    An evidence-based treatment algorithm for colorectal polyp cancers: results from the Scottish Screen-detected Polyp Cancer Study (SSPoCS).
    Gut. 2018;67:299-306.
    PubMed     Text format     Abstract available
    
    
    January 2018
39. WILLIAMS DS, Mouradov D, Jorissen RN, Newman MR, et al
    Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes.
    Gut. 2018 Jan 30. pii: gutjnl-2017-315664. doi: 10.1136/gutjnl-2017-315664.
    PubMed     Text format     Abstract available
    
    
    
40. DE ARCANGELIS A, Chamaillard M, Simon-Assmann P, Labouesse M, et al
    Integrin a6 loss promotes colitis-associated colorectal cancer. Response to: "Integrin a6 variants and colorectal cancer" by Beaulieu JF.
    Gut. 2018 Jan 3. pii: gutjnl-2017-315727. doi: 10.1136/gutjnl-2017-315727.
    PubMed     Text format    
    
    
    
41. BACKES Y, Schwartz MP, Ter Borg F, Wolfhagen FHJ, et al
    Multicentre prospective evaluation of real-time optical diagnosis of T1 colorectal cancer in large non-pedunculated colorectal polyps using narrow band imaging (the OPTICAL study).
    Gut. 2018 Jan 3. pii: gutjnl-2017-314723. doi: 10.1136/gutjnl-2017-314723.
    PubMed     Text format     Abstract available
    
    
    
42. LAWLER M, Alsina D, Adams RA, Anderson AS, et al
    Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer.
    Gut. 2018;67:179-193.
    PubMed     Text format     Abstract available
    
    
    
43. CARBALLAL S, Maisterra S, Lopez-Serrano A, Gimeno-Garcia AZ, et al
    Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD.
    Gut. 2018;67:70-78.
    PubMed     Text format     Abstract available
    
    
    December 2017
44. DEMING DA
    Tailoring the colorectal cancer disease assessment to the treatment strategy.
    Gut. 2017 Dec 21. pii: gutjnl-2017-315394. doi: 10.1136/gutjnl-2017-315394.
    PubMed     Text format    
    
    
    
45. SIEVERS CK, Zou LS, Pickhardt PJ, Matkowskyj KA, et al
    Subclonal diversity arises early even in small colorectal tumours and contributes to differential growth fates.
    Gut. 2017;66:2132-2140.
    PubMed     Text format     Abstract available
    
    
    November 2017
46. WAN L, Yu W, Shen E, Sun W, et al
    SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer.
    Gut. 2017 Nov 7. pii: gutjnl-2017-314983. doi: 10.1136/gutjnl-2017-314983.
    PubMed     Text format     Abstract available
    
    
    
47. GUNDERT M, Edelmann D, Benner A, Jansen L, et al
    Genome-wide DNA methylation analysis reveals a prognostic classifier for non-metastatic colorectal cancer (ProMCol classifier).
    Gut. 2017 Nov 3. pii: gutjnl-2017-314711. doi: 10.1136/gutjnl-2017-314711.
    PubMed     Text format     Abstract available
    
    
    
48. ZORZI M, Hassan C, Capodaglio G, Fedato C, et al
    Long-term performance of colorectal cancer screening programmes based on the faecal immunochemical test.
    Gut. 2017 Nov 3. pii: gutjnl-2017-314753. doi: 10.1136/gutjnl-2017-314753.
    PubMed     Text format     Abstract available
    
    
    October 2017
49. MAZARD T, Boonsirikamchai P, Overman MJ, Asran MA, et al
    Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumab.
    Gut. 2017 Oct 30. pii: gutjnl-2017-313786. doi: 10.1136/gutjnl-2017-313786.
    PubMed     Text format     Abstract available
    
    
    
50. BEAULIEU JF
    Integrin alpha6 variants and colorectal cancer.
    Gut. 2017 Oct 28. pii: gutjnl-2017-315415. doi: 10.1136/gutjnl-2017-315415.
    PubMed     Text format    
    
    
    
51. SCHRAMM C, Janhsen K, Demir M, Nierhoff D, et al
    Serrated polyposis syndrome may go undiagnosed even in structured colorectal cancer screening programmes performed by endoscopists with otherwise good quality indices.
    Gut. 2017 Oct 21. pii: gutjnl-2017-315321. doi: 10.1136/gutjnl-2017-315321.
    PubMed     Text format    
    
    
    
52. FLEMER B, Warren RD, Barrett MP, Cisek K, et al
    The oral microbiota in colorectal cancer is distinctive and predictive.
    Gut. 2017 Oct 7. pii: gutjnl-2017-314814. doi: 10.1136/gutjnl-2017-314814.
    PubMed     Text format     Abstract available
    
    
    
53. BARAULT L, Amatu A, Siravegna G, Ponzetti A, et al
    Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer.
    Gut. 2017 Oct 5. pii: gutjnl-2016-313372. doi: 10.1136/gutjnl-2016-313372.
    PubMed     Text format     Abstract available
    
    
    August 2017
54. ROBERTS SK
    Train-the-trainer education and colonoscopy quality indicators: where to now?
    Gut. 2017;66:1533-1534.
    PubMed     Text format    
    
    
    June 2017
55. BUCHANAN DD, Clendenning M, Zhuoer L, Stewart JR, et al
    Lack of evidence for germline RNF43 mutations in patients with serrated polyposis syndrome from a large multinational study.
    Gut. 2017;66:1170-1172.
    PubMed     Text format    
    
    
    March 2016
56. ADAMI HO, Bretthauer M, Emilsson L, Hernan MA, et al
    The continuing uncertainty about cancer risk in inflammatory bowel disease.
    Gut. 2016 Mar 23. pii: gutjnl-2015-311003. doi: 10.1136/gutjnl-2015-311003.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: